retinatoday.com Open in urlscan Pro
34.202.241.89  Public Scan

Form analysis
1 forms found in the DOM

Name: dt-header-search — GET https://retinatoday.com/search

<form method="GET" action="https://retinatoday.com/search" accept-charset="UTF-8" name="dt-header-search">
  <input type="text" name="q" placeholder="Search">
  <div class="search-icon" id="dt-header-search-trigger"><svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 16 15" xml:space="preserve">
      <style type="text/css">
        .st-search {
          fill: #6E142A;
        }
      </style>
      <path class="st-search" d="M11.9,9.6c0.5-0.9,0.8-2,0.8-3c0-3.4-2.7-6.1-6.1-6.1c-3.4,0-6.1,2.7-6.1,6.1c0,3.4,2.7,6.1,6.1,6.1
	c1.1,0,2.1-0.3,3-0.8l3.8,3.8l2.3-2.3L11.9,9.6z M10.1,6.6c0,1.9-1.6,3.5-3.5,3.5c-1.9,0-3.5-1.6-3.5-3.5c0-1.9,1.6-3.5,3.5-3.5
	C8.5,3.1,10.1,4.7,10.1,6.6z"></path>
    </svg>
  </div>
</form>

Text Content

Facebook Instagram Twitter LinkedIn
YoungMD Connect Eyewire+ Eyetube Podcasts
 * Current Issue
 * Archive
 * Calendar
 * Subscribe



 * AMD
 * Business
 * Diabetes
 * Imaging
 * Meeting Recaps
 * Oncology
 * Rare Diseases
 * Surgery
 * General

 * Topics
   
   
    * AMD
    * Business
    * Diabetes
    * Imaging
    * Meeting Recaps
    * Oncology
    * Rare Diseases
    * Surgery
    * General

 * Current Issue
 * Archive
 * Calendar
 * Subscribe
   YoungMD Connect Podcasts Eyewire+ Eyetube
   

FEATURED




HIGHLIGHTS FROM ARDS 2024

This year’s event included lectures on geographic atrophy, ocular oncology, and
myopic traction maculopathy.

Jason C. Fan, MD, PhD

--------------------------------------------------------------------------------

Know Your E/M Coding in Retina

Medical decision making is usually the determining factor.

Joy Woodke, COE, OCS, OCSR

Infective Endocarditis Detected in Retinal Examination

Ocular findings led to the diagnosis of a rare but potentially fatal infection
in the heart.

Makena Parker, MPHYS, BA; Sarah Syeda, MD; and Mathew W. MacCumber, MD, PhD

Understanding the ROP Epidemic in Africa

First-ever retinopathy of prematurity data from Uganda indicate that the disease
remains largely undiagnosed, with significant barriers to screening and
treatment.

Catherine Manthorp, BA, Senior Editor

Featured Supplements

The Why and How of Going Solo

Editorially independent content supported with advertising by Regeneron and
Iveric Bio

One to Watch: Kapil Mishra, MD

Editorially independent supported by Abbvie and Regenxbio

Rising Stars in Retina: Ellie Xiao Yi Zhou, MD

Editorially independent supported by Abbvie and Regenxbio

Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases

Independent medical education supported by Johnson & Johnson, Neurotech
Pharmaceuticals and Alkeus Pharmaceuticals.
Content supplied by Euretina.

One to Watch: Sarwar Zahid, MD

Editorially independent supported by Abbvie and Regenxbio

Rising Stars in Retina: Farzad Jamshidi, MD, PhD

Editorially independent supported by Abbvie and Regenxbio

View More

Resources

young-md-logo
Group 34





podcast

View More


OCTOBER 2024

October 2024 | Visually Speaking

Bullet Proof: A Case of Chorioretinitis Sclopetaria

Impact from a high-velocity object can lead to this rare condition.

Inês Cerdeira Ludovico, MD; Patrícia Silva, MD; Afonso Murta, MD; Catarina
Barão, MD; Carlos Batalha, MD; and Arnaldo Santos, PhD

October 2024 | Features

Surgical Considerations for Optic Pit Maculopathy

A review of the various surgical techniques to address this rare disorder.

Luke Mavrofrides, and Matthew A. Cunningham, MD, FASRS

October 2024 | Pediatrics

Understanding the ROP Epidemic in Africa

First-ever retinopathy of prematurity data from Uganda indicate that the disease
remains largely undiagnosed, with significant barriers to screening and
treatment.

Catherine Manthorp, BA, Senior Editor

October 2024 | Medical Editors' Page

Problem Solvers Unite

Allen C. Ho, MD, and Robert L. Avery, MD

View Entire Issue


POPULAR ARTICLES

September 2024 Supplement

Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases

Bart Leroy, MD, PhD; Philipp Herrmann, MD, PhD, FEBO; Omar Mahroo, MA, MB,
BChir, PhD, FRCOphth; Hannah L. Scanga, MS, LCGC; and Avril Daly

July/August 2024 Insert

Subthreshold Yellow Laser for Recurrent Central Serous Chorioretinopathy

Giacomo Costa, MD, and Marco Balestrieri, MD

July/August 2024 | Features

The IRD Gene Therapy Pipeline

New research is giving hope to patients with inherited retinal diseases.

Daniel A. Rodriguez, MD; Likhita Nandigam, BS; and Cristy A. Ku, MD, PhD

September 2024 Insert

Rising Stars in Retina: Farzad Jamshidi, MD, PhD

Farzad Jamshidi, MD, PhD

October 2024 Insert

One to Watch: Kapil Mishra, MD

Kapil Mishra, MD

KEEP IN TOUCH

Free Print Subscription

Email Newsletter

Conference Calendar

RETINA NEWS



December 4, 2024

Ophthalmic Industry Veteran Scott Hunter Passes Away

December 4, 2024

EyePoint Announces First Patient Dosed in Phase 3 LUCIA Trial of Duravyu for Wet
AMD

November 27, 2024

Scientists Use Gene Editing to Treat Retinitis Pigmentosa in Mice

November 20, 2024

Melt Pharmaceuticals Announces Positive Phase 3 Trial Results for MELT-300
Sedation Solution



Recent Supplements

One to Watch: Kapil Mishra, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Ellie Xiao Yi Zhou, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases

Independent medical education supported by Johnson & Johnson, Neurotech
Pharmaceuticals and Alkeus Pharmaceuticals.
Content supplied by Euretina.

View Supplement

One to Watch: Sarwar Zahid, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Rising Stars in Retina: Farzad Jamshidi, MD, PhD

Editorially independent supported by Abbvie and Regenxbio

View Insert

AbbVie: Honoring Its Legacy to Guide Its Future

Sponsored by AbbVie

View Insert

View More

Featured Authors

Manish Nagpal, MS, FRCS, FASRS

Ahmedabad, India

Catching Familial Exudative Vitreoretinopathy Early Bietti Crystalline Dystrophy
With Choroidal Caverns Combined Hamartoma of the Retina and RPE Torpedo
Maculopathy

Carol L. Shields, MD



Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma Conditional Survival
of Patients With Uveal Melanoma Choroidal Melanoma: Does Skin Tone Matter?
Uncovering the Truth Behind Choroidal Folds

María H. Berrocal, MD



Tackle Secondary IOLs With Ease How to Mentor Tomorrow’s Retina Leaders Survey
Findings on Vitreous Opacities and Expert Panel Recommendations on the Referral
and Management of Symptomatic Vitreous Opacity Cases How To Perform the
Lift-and-Shave Technique

Eyetube Retina Series



View More

EYETUBE RETINA MEETING COVERAGE



View More


 * AMD
 * Business
 * Diabetes
 * Imaging
 * Meeting Recaps
 * Oncology
 * Rare Diseases
 * Surgery
 * General

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

 * Subscriptions
 * Advertising
 * About
 * Contact
 * Submissions
 * Privacy
 * Archive
 * Resources

Retina Today is a publication that delivers the latest research and clinical
developments from areas such as medical retina, retinal surgery, vitreous,
diabetes, retinal imaging, posterior segment oncology and ocular trauma.



Start A Free Print Or Email Subscription

Request a Media Kit

To manage your subscription, email contact@bmctoday.com

 * Cataract & Refractive Surgery Today
 * Cataract & Refractive Surgery Today Europe
 * Eyetube
 * Eyewire+
 * Glaucoma Today
 * Modern Optometry
 * YoungMD Connect Bookmarked

© 2024 Bryn Mawr Communications, LLC. All Rights Reserved • Privacy Policy

onetrust-logo Created with Sketch.





WE CARE ABOUT YOUR PRIVACY

We and our 18 partners store and/or access information on a device, such as
unique IDs in cookies to process personal data. You may accept or manage your
choices by clicking below, including your right to object where legitimate
interest is used, or at any time in the privacy policy page. These choices will
be signaled to our partners and will not affect browsing data.


WE AND OUR PARTNERS PROCESS DATA TO PROVIDE:

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

I Accept



ABOUT YOUR PRIVACY

We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

STORE AND/OR ACCESS INFORMATION ON A DEVICE 10 PARTNERS CAN USE THIS PURPOSE

Store and/or access information on a device

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

List of IAB Vendors‎ | View Illustrations 

PERSONALISED ADVERTISING AND CONTENT, ADVERTISING AND CONTENT MEASUREMENT,
AUDIENCE RESEARCH AND SERVICES DEVELOPMENT 13 PARTNERS CAN USE THIS PURPOSE

Personalised advertising and content, advertising and content measurement,
audience research and services development

 * USE LIMITED DATA TO SELECT ADVERTISING 11 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on limited data,
   such as the website or app you are using, your non-precise location, your
   device type or which content you are (or have been) interacting with (for
   example, to limit the number of times an ad is presented to you).
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * CREATE PROFILES FOR PERSONALISED ADVERTISING 9 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service (such as forms you submit,
   content you look at) can be stored and combined with other information about
   you (for example, information from your previous activity on this service and
   other websites or apps) or similar users. This is then used to build or
   improve a profile about you (that might include possible interests and
   personal aspects). Your profile can be used (also later) to present
   advertising that appears more relevant based on your possible interests by
   this and other entities.
   
   View Illustrations 

 * USE PROFILES TO SELECT PERSONALISED ADVERTISING 8 PARTNERS CAN USE THIS
   PURPOSE
   
   Switch Label
   
   Advertising presented to you on this service can be based on your advertising
   profiles, which can reflect your activity on this service or other websites
   or apps (like the forms you submit, content you look at), possible interests
   and personal aspects.
   
   View Illustrations 

 * MEASURE ADVERTISING PERFORMANCE 13 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information regarding which advertising is presented to you and how you
   interact with it can be used to determine how well an advert has worked for
   you or other users and whether the goals of the advertising were reached. For
   instance, whether you saw an ad, whether you clicked on it, whether it led
   you to buy a product or visit a website, etc. This is very helpful to
   understand the relevance of advertising campaigns.
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM
   DIFFERENT SOURCES 8 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Reports can be generated based on the combination of data sets (like user
   profiles, statistics, market research, analytics data) regarding your
   interactions and those of other users with advertising or (non-advertising)
   content to identify common characteristics (for instance, to determine which
   target audiences are more receptive to an ad campaign or to certain
   contents).
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

 * DEVELOP AND IMPROVE SERVICES 8 PARTNERS CAN USE THIS PURPOSE
   
   Switch Label
   
   Information about your activity on this service, such as your interaction
   with ads or content, can be very helpful to improve products and services and
   to build new products and services based on user interactions, the type of
   audience, etc. This specific purpose does not include the development or
   improvement of user profiles and identifiers.
   
   View Illustrations 
   Object to Legitimate Interests Remove Objection

List of IAB Vendors‎

ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS 10 PARTNERS CAN USE
THIS PURPOSE

Always Active

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

List of IAB Vendors‎ | View Illustrations 

DELIVER AND PRESENT ADVERTISING AND CONTENT 13 PARTNERS CAN USE THIS PURPOSE

Always Active

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

List of IAB Vendors‎ | View Illustrations 

MATCH AND COMBINE DATA FROM OTHER DATA SOURCES 9 PARTNERS CAN USE THIS PURPOSE

Always Active

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

List of IAB Vendors‎

LINK DIFFERENT DEVICES 5 PARTNERS CAN USE THIS PURPOSE

Always Active

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

List of IAB Vendors‎

IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY 10 PARTNERS CAN
USE THIS PURPOSE

Always Active

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

List of IAB Vendors‎
Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices